search
Back to results

Resiliency Program for Medical Interpreters (CARE)

Primary Purpose

Psychological Stress

Status
Completed
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
Behavioral: Resiliency Intervention
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Psychological Stress focused on measuring Resiliency burnout stress

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Interpreter employed at one of the 3 study hospitals
  2. >=20 hours/week

Exclusion Criteria:

1) Interpreter working <20 hours per week

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    Delayed Intervention: Control

    Experimental: Intervention

    Arm Description

    Delayed intervention: Control was a a behavioral treatment for resiliency delivered in a single 4 hour session delivered in a delayed fashion (waitlist control)

    Experimental: Intervention was a 4 hour behavioral resiliency intervention.

    Outcomes

    Primary Outcome Measures

    Feasibility and Acceptability of Intervention (participant feedback questionnaire)
    A participant feedback questionnaire will be completed by participants, including questions about whether the logistics and content of the intervention were feasible and acceptable to them. Attendance to the sessions is also considered as a component of feasibility.

    Secondary Outcome Measures

    Psychological Variables including Perceived Stress and Resiliency ( PSS-1021 is a 10-item scale)
    The PSS-1021 is a 10-item scale designed to measure the degree to which situations in one's life are appraised, or considered as stressful, and how unpredictable, uncontrollable, and overloaded respondents find their lives. Responses are on 4-item Likert scales and range from 10-40; higher score = greater stress.The Resiliency Scale is a 14-item self-report measure to assess one's ability to successfully deal with adversity.

    Full Information

    First Posted
    June 27, 2014
    Last Updated
    March 3, 2015
    Sponsor
    Massachusetts General Hospital
    Collaborators
    University of Massachusetts, Boston
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02378597
    Brief Title
    Resiliency Program for Medical Interpreters
    Acronym
    CARE
    Official Title
    Developing a Resiliency Program for Medical Interpreters in Cancer Care
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2014 (undefined)
    Primary Completion Date
    March 2014 (Actual)
    Study Completion Date
    June 2014 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Massachusetts General Hospital
    Collaborators
    University of Massachusetts, Boston

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    To develop and test a 4-session program to teach resiliency skills to Medical Interpreters.
    Detailed Description
    This study aims to improve quality of cancer care for LEP patients through improving medical interpreters' ability to cope with difficult encounters. We propose to (1) identify the needs of medical interpreters working with cancer patients, and (2) develop and test a psychoeducational resiliency program at 3 DF/HCC cancer centers: MGH, DFCI, and BWH) intended to enhance interpreters' skills to effectively manage stressful encounters and to cope with the personal effects of encounters.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Psychological Stress
    Keywords
    Resiliency burnout stress

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 1, Phase 2
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    28 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Delayed Intervention: Control
    Arm Type
    Active Comparator
    Arm Description
    Delayed intervention: Control was a a behavioral treatment for resiliency delivered in a single 4 hour session delivered in a delayed fashion (waitlist control)
    Arm Title
    Experimental: Intervention
    Arm Type
    Experimental
    Arm Description
    Experimental: Intervention was a 4 hour behavioral resiliency intervention.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Behavioral: Resiliency Intervention
    Other Intervention Name(s)
    CARE
    Intervention Description
    4 hour behavioral session including education in the relaxation response, education about stress and allostatic load, cognitive skills building, review of difficult encounters with patients.
    Primary Outcome Measure Information:
    Title
    Feasibility and Acceptability of Intervention (participant feedback questionnaire)
    Description
    A participant feedback questionnaire will be completed by participants, including questions about whether the logistics and content of the intervention were feasible and acceptable to them. Attendance to the sessions is also considered as a component of feasibility.
    Time Frame
    Post-Intervention (4 weeks)
    Secondary Outcome Measure Information:
    Title
    Psychological Variables including Perceived Stress and Resiliency ( PSS-1021 is a 10-item scale)
    Description
    The PSS-1021 is a 10-item scale designed to measure the degree to which situations in one's life are appraised, or considered as stressful, and how unpredictable, uncontrollable, and overloaded respondents find their lives. Responses are on 4-item Likert scales and range from 10-40; higher score = greater stress.The Resiliency Scale is a 14-item self-report measure to assess one's ability to successfully deal with adversity.
    Time Frame
    Baseline, Post-Intervention (4 weeks), and 12 week follow up

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Interpreter employed at one of the 3 study hospitals >=20 hours/week Exclusion Criteria: 1) Interpreter working <20 hours per week
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Michele Russell-Einhorn, JD
    Organizational Affiliation
    Dana-Farber Cancer Institute
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    Resiliency Program for Medical Interpreters

    We'll reach out to this number within 24 hrs